Mayo Clinic in Florida
Jacksonville, Florida, 32224-9980, United States
NCT Number: NCT06767475
This clinical trial evaluates the impact of a Mindfulness-Based Stress Reduction (MBSR) program adjusted to include Christian principles on well-being in Black adult cancer survivors. Cancer survivors face a unique set of challenges that includes not only physical but also mental and spiritual well-being. Concerns related to both diagnosis and treatment profoundly impact the quality of life of Black cancer survivors. Mindfulness-based interventions (MBIs) have been shown to be effective in improving psychological resilience, reducing anxiety, and enhancing the quality of life among cancer survivors. However, there is little research focusing on these interventions among Black adult cancer survivors. Research has shown that interventions that include cultural experiences, such as the role of religion, spirituality and faith, are more effective in maintaining psychological well-being in Black men. A MBSR program adjusted to include Christian principles may improve the well-being in Black adult cancer survivors.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
Jacksonville, Florida, 32224-9980, United States
PRIMARY OBJECTIVES:
I. Develop a culturally adapted Mindfulness-Based Stress Reduction (MBSR) intervention. (Phase 0) II. Pilot test the MBSR intervention to assess its feasibility, acceptability, and preliminary efficacy among a small group of participants. (Phase 0) III. To implement an overnight silent mindfulness retreat intervention that incorporates faith based cultural adaptations tailored for Black participants. (Phase I)
OUTLINE:
PHASE 0:
INTERVENTION DEVELOPMENT: Participants attend a focus group or a one-on-one interview over up to 60 minutes to gather insights of the cultural needs of Black adult cancer survivors.
PILOT TESTING: Patients participate in a group discussion with exercises and activities on study.
After completion of study intervention, patients are followed up at 3 months.
PHASE 1: Patients participate an overnight silent mindfulness retreat intervention, over 31 hours, with faith-based cultural adaptation emphasizing resilience and cultural relevant spiritual framing. The retreat includes sessions on different types of meditation, working with thoughts and emotions, stress, mindfulness techniques and how to integrate them, positive mind states, resiliency and resources, including educational handouts.
After completion of study intervention, patients are followed up at 3 and 6 months.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Receive education resource handouts
Other names: Education for Intervention, Intervention by Education, Intervention through Education, Intervention, Educational
Attend a focus group
Other names: Discuss
Complete silent mindfulness retreat intervention
Other names: MBSR, Mindful Meditation, Mindfulness Meditation, Mindfulness-Based Stress Reduction (MBSR)
Attend a one-on-one interview
Complete study-related questionnaires
Time frame: Pre-MBI, Post-MBI (immediately after MBI), 3 months, 6months
Will be measured by the change in scores on the Functional Assessment of Chronic Illness Therapy-Spiritual Well-Being Scale (FACIT-Sp-12). The FACIT-Sp-12a is a 12-item scale measuring spiritual well-being over the past 7 days. Responses are on a 5 point Likert-type scale (0=not at all; 1=a little bit, 2=somewhat; 3=quite a bit; 4=very much) with higher scores generally representing greater well-being
Time frame: Pre-MBI, Post-MBI, 3 months, 6months
Will be evaluated using changes in health related QOL patient reported outcomes responses. The World Health Organization Quality of Life Brief Version (WHOQOL-BREF) will be used to assess spiritual, religious or personal beliefs and how these beliefs have affected QOL including positive feelings, social support, self-esteem, pain, energy, work capacity, health and social care, and leisure activities. The WHOQOL-BREF is a 26-question instrument consisting of four domains. Each individual item of the WHOQOL-BREF is scored from 1-5 on a five-point ordinal scale.
Time frame: Pre-MBI, Post-MBI, 3 months, 6months
Will be measured by the Connor- Davidson Resilience Scale (CD-RISC). The CD-RISC is comprised of 25 items, each rated on a 5-point scale (0-4), with higher scores reflecting greater resilience.
Time frame: Pre-MBI, Post-MBI, 3 months, 6months
Will be measured by the Resilience Scale for Adults (RSA). The RSA examines intrapersonal and interpersonal protective factors presumed to facilitate adaptation to psychosocial adversities, as well as family and social protective factors of resilience. The RSA has 33 items; item-response ranges from one to seven; higher scores reflect higher levels of protective factors of resilience.
Time frame: Post-MBI, 3 months, 6months
Will be assessed using the Was It Worth It (WIWI) questionnaire to determine changes in participants view on the worthiness of the intervention. Responses to the WIWI will capture participants' subjective evaluations of the intervention's impact. WIWI is a 3-item questionnaire with yes or no responses.
Mayo Clinic
Other
Effectiveness of Mindfulness-Based Intervention on Patient Reported Outcomes of Black Adult Cancer Survivors: A Community Faith-Based Mindfulness Ministry (ComFaMM) Trial
Acronym: ComFaMM
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07307833
Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm
Scottsdale, Arizona, United States
View Trial DetailsNCT07594496
Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm
Scottsdale, Arizona, United States
View Trial DetailsNCT07215039
Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm
Jacksonville, Florida, United States
View Trial DetailsNCT07225920
Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm
Tuscaloosa, Alabama, United States
View Trial Details